26-05-2025
Roche moves antibiotic against superbug into Phase 3 of testing
FRANKFURT, May 26 (Reuters) - Swiss drugmaker Roche (ROG.S), opens new tab said on Monday it would advance testing of an antibiotic against a common drug-resistant bacteria that causes serious hospital infections into the third and last phase of testing on humans.
Roche said in a statement that the experimental antibiotic zosurabalpin, jointly developed with Harvard University, would be tested against acinetobacter baumannii, relying on a new mode of action that bacteria have not developed resistance against.
Drug-resistant acinetobacter are present across the world and disproportionately impact patients who are in hospital, causing serious infections like pneumonia and sepsis, the company added.
